Flow cytometric analysis of apoptosis and BCL-2 in primary breast carcinomas: Clinical and biological implications

被引:0
|
作者
Steck, K
McDonnell, T
Sneige, N
ElNaggar, A
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC PATHOL,HOUSTON,TX 77030
来源
CYTOMETRY | 1996年 / 24卷 / 02期
关键词
flow cytometry; mammary carcinoma; bcl-2; apoptosis;
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Analysis of programmed cell death (apoptosis), of bcl-2, a critical regulator of this process, and of the proliferative fraction may provide detailed information on the biologic characteristics of tumor cell populations, To investigate the potential role of these parameters in assessing mammary carcinoma, we adapted flow cytometric procedures for concurrent measurement of apoptosis, bcl-2 expression, and cell proliferation in 54 primary breast carcinomas and correlated the findings with traditional clinicopathologic information. Overall, a significant inverse relationship between apoptosis levels and bcl-2 expression was observed (P = 0.005). Apoptosis levels correlated significantly with DNA aneuploidy (P = 0.03) and S + G2M fractions (P = 0.005) of these tumors, A significant correlation between bcl-2 expression and estrogen receptor positivity (P = 0.05) and DNA diploidy (P = 0.02) was noted. Bcl-2 expression, however, was inversely correlated with S + G2M fractions (P = 0.001), We conclude that analysis of apoptosis and bcl-2 by flow cytometry allows further characterization of tumor cell populations that may be useful for prognostic and therapeutic management of breast carcinoma. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 50 条
  • [1] FLOW CYTOMETRIC ANALYSIS OF APOPTOSIS AND BCL-2 IN HUMAN SOLID NEOPLASMS
    STECK, KD
    MCDONNELL, TJ
    ELNAGGAR, AK
    CYTOMETRY, 1995, 20 (02): : 154 - 161
  • [2] bcl-2 expression and apoptosis in primary and metastatic breast carcinomas
    Villar, E
    Redondo, M
    Rodrigo, I
    García, J
    Avila, E
    Matilla, A
    TUMOR BIOLOGY, 2001, 22 (03) : 137 - 145
  • [3] BCL-2 PROTEIN IN INVASIVE DUCTAL BREAST CARCINOMAS
    HURLIMANN, J
    LARRINAGA, B
    VALA, DLM
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1995, 426 (02): : 163 - 168
  • [4] The role of bcl-2 expression in breast carcinomas (Review)
    Zhang, GJ
    Kimijima, I
    Tsuchiya, A
    Abe, R
    ONCOLOGY REPORTS, 1998, 5 (05) : 1211 - 1216
  • [5] Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas
    Gobé, G
    Rubin, M
    Williams, G
    Sawczuk, I
    Buttyan, R
    CANCER INVESTIGATION, 2002, 20 (03) : 324 - 332
  • [6] APOPTOSIS SUPPRESSING PROTEIN BCL-2 IS EXPRESSED IN WELL-DIFFERENTIATED BREAST CARCINOMAS WITH FAVORABLE PROGNOSIS
    LIPPONEN, P
    PIETILAINEN, T
    KOSMA, VM
    AALTOMAA, S
    ESKELINEN, M
    SYRJANEN, K
    JOURNAL OF PATHOLOGY, 1995, 177 (01) : 49 - 55
  • [7] In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis
    Rochaix, P
    Krajewski, S
    Reed, JC
    Bonnet, F
    Voigt, JJ
    Brousset, P
    JOURNAL OF PATHOLOGY, 1999, 187 (04) : 410 - 415
  • [8] Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis
    DiGiuseppe, JA
    LeBeau, P
    Augenbraun, J
    Borowitz, MJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 106 (03) : 345 - 351
  • [9] Flow cytometric analysis of serum deprivation-induced apoptosis of PC12 cells, with special reference to role of bcl-2
    Satoh, T
    Sakai, N
    Kubo, T
    Enokido, Y
    Uchiyama, Y
    Hatanaka, H
    NEUROSCIENCE LETTERS, 1995, 201 (02) : 119 - 122
  • [10] Bcl-2 protein family: Implications in vascular apoptosis and atherosclerosis
    Ozgur Kutuk
    Huveyda Basaga
    Apoptosis, 2006, 11 : 1661 - 1675